Evidence map›Paper›PMID 37250693›Full record

ArticleFrontiers in human neuroscience2023

Art therapy as a comprehensive complementary treatment for Parkinson's disease.

Tom Ettinger, Marygrace Berberian, Ikuko Acosta, Alberto Cucca, Andrew Feigin, Danilo Genovese, Travis Pollen, Julianne Rieders, Rohita Kilachand, Clara Gomez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in human neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
19.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Improving Conversations about Parkinson's Dementia.Movement disorders clinical practice · 2024
    Article
  11. Article
  12. If Art Were a Drug: Implications for Parkinson's Disease.Journal of Parkinson's disease · 2024
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Tom EttingerSteinhardt Graduate Art Therapy Program, New York University, New York, NY, United States.
Marygrace BerberianSteinhardt Graduate Art Therapy Program, New York University, New York, NY, United States.
Ikuko AcostaSteinhardt Graduate Art Therapy Program, New York University, New York, NY, United States.
Alberto CuccaDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
Andrew FeiginDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
Danilo GenoveseDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
Travis PollenDepartment of Exercise Science, Thomas Jefferson University, Philadelphia, PA, United States.
Julianne RiedersDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
Rohita KilachandSteinhardt Graduate Art Therapy Program, New York University, New York, NY, United States.
Clara GomezSteinhardt Graduate Art Therapy Program, New York University, New York, NY, United States.
Girija KaimalCreative Arts Therapies, Drexel University, Philadelphia, PA, United States.
Milton BiagioniDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
Alessandro Di RoccoZucker School of Medicine at Hofstra Northwell, New York, NY, United States.
Felice M GhilardiDepartment of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Grossman School of Medicine, New York, NY, United States.
John-Ross RizzoDepartment of Rehabilitation Medicine, New York University Grossman School of Medicine, New York, NY, United States.
New York University · USDrexel University · USHofstra University · USThomas Jefferson University · USUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. Complementary and alternative therapies are increasingly utilized to address its complex multisystem symptomatology. Art therapy involves motoric action and visuospatial processing while promoting broad biopsychosocial wellness. The process involves hedonic absorption, which provides an escape from otherwise persistent and cumulative PD symptoms, refreshing internal resources. It involves the expression in nonverbal form of multilayered psychological and somatic phenomena; once these are externalized in a symbolic arts medium, they can be explored, understood, integrated, and reorganized through verbal dialogue, effecting relief and positive change. Methods: 42 participants with mild to moderate PD were treated with 20 sessions of group art therapy. They were assessed before and after therapy with a novel arts-based instrument developed to match the treatment modality for maximum sensitivity. The House-Tree-Person PD Scale (HTP-PDS) assesses motoric and visuospatial processing-core PD symptoms-as well as cognition (thought and logic), affect/mood, motivation, self (including body-image, self-image, and self- efficacy), interpersonal functioning, creativity, and overall level of functioning. It was hypothesized that art therapy will ameliorate core PD symptoms and that this will correlate with improvements in all other variables. Results: HTP-PDS scores across all symptoms and variables improved significantly, though causality among variables was indeterminate. Discussion: Art therapy is a clinically efficacious complementary treatment for PD. Further research is warranted to disentangle causal pathways among the aforementioned variables, and additionally, to isolate and examine the multiple, discrete healing mechanisms believed to operate simultaneously in art therapy.

Indexed as

art based assessmentart makingart therapyneurodegenerative disorderParkinson’s disease

Identifiers

PMID37250693
PMCPMC10215005
OpenAlexW4376275947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.